178 related articles for article (PubMed ID: 28247188)
1. Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes.
Li W; Ward R; Valenzuela JP; Dong G; Fagan SC; Ergul A
Transl Stroke Res; 2017 Mar; ():. PubMed ID: 28247188
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats.
Li W; Qu Z; Prakash R; Chung C; Ma H; Hoda MN; Fagan SC; Ergul A
Brain Res; 2013 Dec; 1541():106-14. PubMed ID: 24144674
[TBL] [Abstract][Full Text] [Related]
3. Post-stroke neovascularization and functional outcomes differ in diabetes depending on severity of injury and sex: Potential link to hemorrhagic transformation.
Li W; Valenzuela JP; Ward R; Abdelbary M; Dong G; Fagan SC; Ergul A
Exp Neurol; 2019 Jan; 311():106-114. PubMed ID: 30243988
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.
Hafez S; Hoda MN; Guo X; Johnson MH; Fagan SC; Ergul A
Transl Stroke Res; 2015 Jun; 6(3):171-80. PubMed ID: 25683354
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
Shehadah A; Chen J; Cui Y; Zhang L; Roberts C; Lu M; Chopp M
J Neurol Sci; 2011 Oct; 309(1-2):96-101. PubMed ID: 21802695
[TBL] [Abstract][Full Text] [Related]
6. Combining statins with tissue plasminogen activator treatment after experimental and human stroke: a safety study on hemorrhagic transformation.
Campos M; García-Bonilla L; Hernández-Guillamon M; Barceló V; Morancho A; Quintana M; Rubiera M; Rosell A; Montaner J
CNS Neurosci Ther; 2013 Nov; 19(11):863-70. PubMed ID: 24118905
[TBL] [Abstract][Full Text] [Related]
7. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
[TBL] [Abstract][Full Text] [Related]
8. Treatment of stroke in aged male and female rats with Vepoloxamer and tPA reduces neurovascular damage.
Zhang L; Luo H; Li C; Teng H; Powell B; Lu M; Chopp M; Zhang ZG
Front Neurol; 2023; 14():1282736. PubMed ID: 37869138
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator treatment of stroke in type-1 diabetes rats.
Ning R; Chopp M; Yan T; Zacharek A; Zhang C; Roberts C; Cui X; Lu M; Chen J
Neuroscience; 2012 Oct; 222():326-32. PubMed ID: 22820263
[TBL] [Abstract][Full Text] [Related]
10. Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
Cheng G; Zhao W; Xin Y; Huang G; Liu Y; Li Z; Zhan M; Li Y; Lu L; van Leyen K; Liu Y
J Neurochem; 2021 May; 157(3):586-598. PubMed ID: 33481248
[TBL] [Abstract][Full Text] [Related]
11. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
[TBL] [Abstract][Full Text] [Related]
12. Cerebral microvascular matrix metalloproteinase-3 (MMP3) contributes to vascular injury after stroke in female diabetic rats.
Abdul Y; Jamil S; Li W; Ergul A
Neurochem Int; 2023 Jan; 162():105462. PubMed ID: 36509234
[TBL] [Abstract][Full Text] [Related]
13. tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.
Shi K; Zou M; Jia DM; Shi S; Yang X; Liu Q; Dong JF; Sheth KN; Wang X; Shi FD
Circ Res; 2021 Jan; 128(1):62-75. PubMed ID: 33070717
[TBL] [Abstract][Full Text] [Related]
14. Acute Hyperglycemia Exacerbates Hemorrhagic Transformation after Embolic Stroke and Reperfusion with tPA: A Possible Role of TXNIP-NLRP3 Inflammasome.
Salman M; Ismael S; Li L; Ahmed HA; Puchowicz MA; Ishrat T
J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106226. PubMed ID: 34847489
[TBL] [Abstract][Full Text] [Related]
15. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
16. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Jin R; Xiao AY; Liu S; Wang M; Li G
Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
[TBL] [Abstract][Full Text] [Related]
17. Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats.
Jin R; Zhu X; Li G
J Vis Exp; 2014 Sep; (91):51956. PubMed ID: 25285809
[TBL] [Abstract][Full Text] [Related]
18. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
19. Early administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke.
Wang Z; Shan W; Cao J; Wintermark M; Huang W; Zuo Z
J Neurosci Res; 2018 Mar; 96(3):449-458. PubMed ID: 28976017
[TBL] [Abstract][Full Text] [Related]
20. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
